Accelerating Vaccinations Produce Real World Benefits

The Buenos Aires Ministry of Health in Argentina confirmed the efficacy of the Sputnik V vaccine and others in protecting older individuals from severe COVID-19.

This recent study found that within the first five months after the start of the local vaccination campaign, COVID-19 vaccination was associated with a significant reduction in COVID-19 infection as well as a reduction in mortality.

The peer-reviewed study has been published by The Journal of the American Medical Association on October 29, 2021, showed that infection rates decreased by over 88% among those who received the complete, two-dose vaccination against COVID-19.

And, full vaccination was associated with a 96.6% reduction in mortality.

Furthermore, the entire vaccination schedule was associated with a 94.2% reduction of all-cause deaths among those aged at least 80 years and 98.2% among those aged 70 to 79 years.

These findings suggest that practical use of available COVID-19 vaccines may significantly reduce morbidity and mortality, stated these researchers.

The present analysis shows that the pragmatic implementation of a vaccination plan including different COVID-19 vaccine options in older adults in the City of Buenos Aires was associated with a significant reduction in documented COVID-19 infection and death from any cause as death presumably associated with COVID-19.

These study results suggest the need to implement mass COVID-19 vaccination strategies in the shortest possible time.